Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors

By Kuppens I.   Witteveen P.   Schot M.   Schuessler V.   Daehling A.   Beijnen J.   Voest E.   Schellens J.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 227-235

Springer Publishing Company

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

By Hilgers Werner   Faivre Sandrine   Chieze Stéphanie   Alexandre Jérôme   Lokiec François   Goldwasser François   Raymond Eric   Kahatt Carmen   Taamma Abdelkrim   Weems Garry   MacDonald John   Misset Jean-Louis   Cvitkovic Esteban  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 311-319

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

By Vidal Laura  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 616-628

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study

By Davies Angela   Ho Cheryl   Hesketh Paul   Beckett Laurel   Lara Primo   Lau Derick   Gandara David  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 351-355

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors

By Camacho Luis   Olson Jon   Tong William   Young Charles   Spriggs David   Malkin Mark  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite